Cargando…
Gene signature associated with resistance to fluvastatin chemoprevention for breast cancer
BACKGROUND: Although targeting of the cholesterol pathway by statins prevents breast cancer development in mouse models, efficacy is not absolute. Therefore, the goal of this study is to investigate if the upregulation in the cholesterol biosynthesis pathway genes associates with response to statin...
Autores principales: | Bhardwaj, Anjana, Embury, Matthew D., Ju, Zhenlin, Wang, Jing, Bedrosian, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928625/ https://www.ncbi.nlm.nih.gov/pubmed/35296281 http://dx.doi.org/10.1186/s12885-022-09353-2 |
Ejemplares similares
-
Efficacy of fluvastatin and aspirin for prevention of hormonally insensitive breast cancer
por: Bhardwaj, Anjana, et al.
Publicado: (2021) -
Integrative Analyses of Multilevel Omics Reveal Preneoplastic Breast to Possess a Molecular Landscape That is Globally Shared with Invasive Basal-Like Breast Cancer (Running Title: Molecular Landscape of Basal-Like Breast Cancer Progression)
por: Ju, Zhenlin, et al.
Publicado: (2020) -
Erratum: Ju, Z., et al. Integrative Analyses of Multilevel Omics Reveal Preneoplastic Breast to Possess a Molecular Landscape That Is Globally Shared with Invasive Basal-Like Breast Cancer (Running Title: Molecular Landscape of Basal-Like Breast Cancer Progression). Cancers 2020, 12, 722
por: Ju, Zhenlin, et al.
Publicado: (2020) -
The molecular heterogeneity of the precancerous breast affects drug efficacy
por: Bhardwaj, Anjana, et al.
Publicado: (2022) -
Enantiospecific Pharmacogenomics of Fluvastatin
por: Hirvensalo, Päivi, et al.
Publicado: (2019)